NUMG - ETF AI Analysis
Top Page
Nuveen ESG Mid-Cap Growth ETF (NUMG)
Rating:69Neutral
Price Target:―
Positive Factors
Strong Performance From Several Top Holdings
Many of the largest positions, especially in technology and industrials, have shown strong gains this year, helping support the ETF’s overall results.
Broad Sector Diversification Within Mid-Cap Growth
The fund spreads its investments across multiple sectors like technology, industrials, health care, consumer cyclical, and financials, which helps reduce the impact if any one industry struggles.
Moderate Expense Ratio For an ESG Strategy
The ETF’s fee is reasonable for a specialized ESG mid-cap growth fund, so less of your potential return is eaten up by costs compared with many niche products.
Negative Factors
Recent Weak Year-To-Date Performance
Despite some strong individual stocks, the ETF’s overall performance so far this year has been weak, which may concern investors looking for steady growth.
Concentration in U.S. Stocks Only
Almost all of the ETF’s holdings are in U.S. companies, so it offers little geographic diversification and is heavily tied to the U.S. market’s fortunes.
Mixed Results Among Top Holdings
A few of the larger positions have been lagging this year, which can drag on the fund’s returns if those stocks do not improve.
NUMG vs. SPDR S&P 500 ETF (SPY)
AUM345.24M
RegionNorth America
Expense Ratio0.31%
Beta1.12
IssuerNuveen
Inception DateDec 13, 2016
Dividend Yield0.01%
Asset ClassEquity
Index TrackedMSCI Nuveen ESG USA Mid Cap Growth
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume12,741
30 Day Avg. Volume18,126
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
58.45Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering45
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NUMG Summary
Nuveen ESG Mid-Cap Growth ETF (NUMG) follows the MSCI Nuveen ESG USA Mid Cap Growth index, focusing on medium‑sized U.S. companies that are growing quickly and meet strict environmental, social, and governance (ESG) standards. It holds innovative businesses across technology, industrials, health care, and consumer sectors, including well-known names like eBay and Axon Enterprise. Someone might invest in NUMG to seek long-term growth while supporting companies that aim to operate responsibly and sustainably. A key risk is that mid-cap growth and tech-focused stocks can be more volatile, so the ETF’s value can go up and down sharply with the market.
How much will it cost me?The Nuveen ESG Mid-Cap Growth ETF (NUMG) has an expense ratio of 0.31%, which means you’ll pay $3.10 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, focusing on selecting mid-cap growth companies that meet strict ESG criteria.
What would affect this ETF?The Nuveen ESG Mid-Cap Growth ETF (NUMG) could benefit from increased interest in ESG investing and the growth potential of mid-cap companies, particularly in sectors like Technology and Health Care, which are known for innovation. However, it may face challenges from economic downturns, rising interest rates that could impact growth stocks, or regulatory changes affecting ESG criteria. Its focus on U.S. mid-cap stocks also makes it sensitive to domestic economic conditions and sector-specific trends.
NUMG Top 10 Holdings
NUMG is leaning hard into U.S. mid-cap tech and growth names, with software and digital infrastructure setting the tone. Atlassian and MongoDB have been rising, giving the fund a helpful tailwind, while Lumentum’s strong run adds extra juice from the semiconductor side. Datadog and Comfort Systems have cooled off lately, but their longer-term uptrends still support the portfolio. Idexx Laboratories is losing steam and slightly drags on results. Overall, the ETF is a tech-heavy, U.S.-focused growth story with ESG as its guiding compass.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Lumentum Holdings | 4.64% | $16.05M | $83.50B | 451.72% | 61 Neutral | |
| Comfort Systems | 3.82% | $13.21M | $58.12B | 107.01% | 80 Outperform | |
| Ciena | 3.30% | $11.43M | $49.46B | 152.08% | 70 Outperform | |
| Veeva Systems | 3.03% | $10.48M | $42.13B | -6.33% | 66 Neutral | |
| Keysight Technologies | 3.01% | $10.42M | $57.03B | 88.04% | 77 Outperform | |
| Idexx Laboratories | 2.92% | $10.09M | $40.31B | -22.02% | 78 Outperform | |
| Atlassian | 2.74% | $9.47M | $48.61B | 13.59% | 66 Neutral | |
| EMCOR Group | 2.69% | $9.29M | $33.09B | 18.68% | 73 Outperform | |
| Resmed | 2.66% | $9.22M | $32.46B | -17.64% | 76 Outperform | |
| Alnylam Pharma | 2.65% | $9.16M | $32.06B | -47.18% | 60 Neutral |
NUMG Technical Analysis
Neutral
―
Price Trends
46.95
Negative
46.45
Negative
45.66
Positive
Market Momentum
-0.53
Positive
47.42
Neutral
52.40
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NUMG, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 46.55, equal to the 50-day MA of 46.95, and equal to the 200-day MA of 45.66, indicating a neutral trend. The MACD of -0.53 indicates Positive momentum. The RSI at 47.42 is Neutral, neither overbought nor oversold. The STOCH value of 52.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NUMG.
NUMG Peer Comparison
Comparison Results
Performance Comparison
NUMG
Nuveen ESG Mid-Cap Growth ETF
46.25
-3.11
-6.30%
FNY
First Trust Mid Cap Growth AlphaDEX Fund
―
―
―
RFG
Invesco S&P Midcap 400 Pure Growth ETF
―
―
―
GLRY
Inspire Faithward Mid Cap Momentum ESG ETF
―
―
―
FRTY
Alger Mid Cap 40 ETF
―
―
―
TMFM
Motley Fool Mid-Cap Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents